Viking Therapeutics (VKTX)

8.28 +0.28 (3.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/7/19 *Est.)

Latest Headlines

Readthrough to Viking Therapeutic (VKTX) from Ligand (LGND) Short Report is 'Ridiculous' - Raymond James January 17, 2019 7:35 AM - StreetInsider Form 4 Viking Therapeutics, For: Jan 03 Filed by: MORNEAU MICHAEL January 3, 2019 8:37 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 03 Filed by: Masamune Hiroko January 3, 2019 8:35 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 03 Filed by: Lian Brian January 3, 2019 8:32 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 02 Filed by: Webster Stephen W January 3, 2019 8:30 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW January 3, 2019 8:29 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 02 Filed by: FOEHR MATTHEW W January 3, 2019 8:28 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 02 Filed by: MACARTNEY LAWSON January 3, 2019 8:24 PM - SEC Filing Form 4 Viking Therapeutics, For: Jan 02 Filed by: Rowland Charles A Jr January 3, 2019 8:22 PM - SEC Filing Celgene, TESARO Deals Positive for SMID Cap Biotech - SunTrust January 3, 2019 10:34 AM - StreetInsider Viking Therapeutics to Present at Biotech Showcase 2019 January 2, 2019 7:30 AM - PR NewsWire B.Riley/FBR Starts Viking Therapeutic (VKTX) at Buy December 12, 2018 4:27 AM - StreetInsider Pre-Open Movers 11/19: (AKER) (ZAYO) (REN) Higher; (SPB) (XEC) (MDGL) Lower (more...) November 19, 2018 9:23 AM - StreetInsider Raymond James Upgrades Viking Therapeutic (VKTX) to Strong Buy November 19, 2018 5:59 AM - StreetInsider Form SC 13D/A Viking Therapeutics, Filed by: LIGAND PHARMACEUTICALS INC November 13, 2018 5:04 PM - SEC Filing Pre-Open Movers 11/13: (EYEG) (VERI) (BZH) Higher; (EVER) (EB) (TSN) Lower (more...) November 13, 2018 9:27 AM - StreetInsider Viking Therapeutics (VKTX) Reports Results from Phase 2 Study of VK2809 in Patients with NAFLD & Elevated LDL-Cholesterol November 13, 2018 5:53 AM - StreetInsider Viking Therapeutics Presents Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol in Oral Late-Breaker Presentation at The Liver November 12, 2018 6:55 PM - PR NewsWire Viking Therapeutic (VKTX) PT Lowered to $22.50 at Roth Capital November 9, 2018 11:02 AM - StreetInsider Viking Therapeutics (VKTX) Briefly Falls to Low November 8, 2018 10:41 AM - StreetInsider Form 10-Q Viking Therapeutics, For: Sep 30 November 7, 2018 5:05 PM - SEC Filing Viking Therapeutics (VKTX) Tops Q3 EPS by 1c November 7, 2018 4:53 PM - StreetInsider Form 8-K Viking Therapeutics, For: Nov 07 November 7, 2018 4:28 PM - SEC Filing Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update November 7, 2018 4:05 PM - PR NewsWire Viking Therapeutics to Report Financial Results for Third Quarter 2018 on November 7, 2018 October 31, 2018 7:35 AM - PR NewsWire Detailed Research: Economic Perspectives on Paychex, Coty, Bright Scholar Education, LendingClub, Energy Fuels, and Viking Therapeutics — What Drives Growth in Today's Competitive Landscape October 24, 2018 9:25 AM - Globe NewsWire Full Article List